Acupuncture techniques for COPD: a systematic review

Fernández, Carles; Vilaró, Jordi; Fei, Yutong; Wang, Congcong; Liu, Jianping; Huang, Na; Xia, Ruyu; Xia, Tian; R, Hu; Li, Wen; Yu, Min; Gómara-Toldrà, Natàlia; Solà-Madurell, Mireia; Sitjà-Rabert, Mercè

doi:10.1186/s12906-020-02899-3

Cited by 12 publications

(14 citation statements)

References 23 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Several meta-analyses of AT treatment for COPD have been previously performed. [ 57 – 61 ] However, our study has some differences and advantages over them. Our study has the largest sample size (28 trials, 2130 participants), thus improving the statistical power.…”

Section: Discussionmentioning

confidence: 98%

Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis

Zhang

Wang

2023

Medicine

View full text Add to dashboard Cite

Background: Acupuncture therapy (AT) is a widely used, alternative medicine in China. AT is an effective treatment for many diseases, but its efficacy in stable chronic obstructive pulmonary disease (COPD) remains controversial. Therefore, we performed the present meta-analysis to evaluate the efficacy of AT in stable COPD patients. Methods: Randomized controlled trials (RCTs) for AT efficacy in stable COPD patients were searched in literature databases from the inception to December 31, 2021. Pooled effect sizes of outcome measurements with respect to lung function (forced vital capacity [FVC], forced expiratory volume in 1 second [FEV 1 ], FEV 1 in predicted value [FEV 1 %], FEV 1 /FVC), quality of life (St. George respiratory questionnaire [SGRQ]), exercise capacity (6-minute walking distance [6MWD]) and effective rate were estimated by calculating weighted mean difference (WMD) or odds ratio (OR) with corresponding 95% confidence interval (95% CI), respectively, by a random-effect model. Results: A total of 28 RCTs with 2130 COPD patients were included. AT group had significant improvement in FVC (WMD = 0.29 L, 95% CI: 0.22–0.36, P < .001), FEV 1 (WMD = 0.33 L, 95% CI: 0.23–0.43, P < .001), FEV 1 % (WMD = 3.30%, 95% CI: 3.30–4.64, P < .001), FEV 1 /FVC (WMD = 5.45%, 95% CI: 4.41–6.49, P < .001), 6MWD (WMD = 45.48 m, 95% CI: 28.21–62.16, P < .001), SGRQ (WMD = −7.79, 95% CI: −12.34 to −3.24, P < .001), and a higher effective rate (OR = 3.71, 95% CI: 2.50–5.52, P < .001) compared to the control group. Subgroup analysis stratified by comparison model (AT combined with other treatments vs other treatments, AT alone vs sham AT) and treatment duration (≥8 weeks, <8 weeks) also showed more improvement in AT arm than control arm without significant between-subgroup difference. Adverse events were reported in a few studies and only mild reactions were observed. Conclusion: AT is effective in improving lung function, quality of life and exercise capacity, and can be used as an adjunctive treatment in patients with stable COPD.

show abstract

Section: Discussionmentioning

confidence: 98%

Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis

Zhang

Wang

2023

Medicine

View full text Add to dashboard Cite

show abstract

“…Fernández-Jané et al indicated that in stable COPD patients, filiform needle acupuncture added to usual treatment improved dyspnea, HRQL, and exercise capacity (42). Fernández-Jané also suggested that acupressure could improve dyspnea, HRQL, and anxiety in patients with stable COPD (43). These meta-analysis studies revealed the effectiveness of acupuncture therapy, specifically A and AM, in treating patients with COPD.…”

Section: Discussionmentioning

confidence: 98%

Acupuncture Point Stimulation Treatments Combined With Conventional Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis

Tsai

Cui

et al. 2021

Front. Med.

View full text Add to dashboard Cite

Background: Chronic obstructive pulmonary disease (COPD), which is a disease characterized by dyspnea, cough, and respiratory symptoms, leading to impaired health-related quality of life (HRQL) and exercise capacity, is highly prevalent worldwide. Some studies demonstrated that acupuncture point stimulation treatments (APSTs) are effective and safe in treating patients with COPD. The aim of this systematic review and network meta-analysis is to analyze the effects on HRQL and FEV1% predicted of diverse APSTs in treating patients with COPD.Materials and Methods: We searched seven electronic databases. Randomized controlled trials (RCTs) with stable COPD patients comparing APSTs and conventional treatment (Tx) were included. The primary outcome was HRQL measured by COPD Assessment Test or St. George's Respiratory Questionnaire. The secondary outcome was FEV1% predicted. We performed random effect network meta-analysis using a consistency model.Results: This network meta-analysis analyzed 21 RCTs with 1,577 stable COPD participants. In comparison with Tx, acupressure massage (AM) + Tx [−5.11; 95% confidence interval (CI), −6.65 to −3.57] was the most effective intervention in improving HRQL, followed by moxibustion (Mx) + Tx (−2.86; 95% CI, −3.86 to −1.86). Moreover, in comparison with Tx, Mx + Tx (7.79; 95% CI, 2.16 to 13.42) was the most effective intervention in improving FEV1% predicted, followed by acupuncture (A) + Tx (5.79; 95% CI, 2.90 to 8.68).Conclusions: Combined interventions (APSTs + Tx) are more effective than single intervention in improving both HRQL and FEV1% predicted. AM, Mx, and A can be considered effective non-pharmacological complementary interventions in treating patients with COPD under Tx.

show abstract

“…The underlying mechanisms of acupuncture on breathlessness have been covered in previous studies. [17][18][19] Acupuncture may target various aspects of the pathological process of breathlessness such as central role of endogenous opioid peptide release, 20 anti-inflammatory effect of epinephrine corticosteroid release 21 and psychological effects. 22 Why it is important to perform this review Nowadays, there is no approved therapy to control breathlessness in advanced cancer.…”

Section: How the Intervention Might Workmentioning

confidence: 99%

Acupuncture for breathlessness in advanced cancer: a protocol for systematic review and meta-analysis with trial sequential analysis

Yin

Sun

et al. 2021

BMJ Open

View full text Add to dashboard Cite

IntroductionBreathlessness in advanced cancer, a frequent multicomponent and debilitating disorder, severely reduces function and quality of patients’ life. Multiple studies have shown that non-pharmacological therapies can effectively palliate breathlessness in advanced cancer. However, no systematic review has investigated the application of acupuncture, as a non-pharmacological treatment, for breathlessness in advanced cancer. A systematic review will be conducted to summarise evidence supporting the efficacy and safety of acupuncture as a therapeutic option for breathlessness in advanced cancer based on existing randomised controlled trials (RCTs).MethodsRCTs will be retrieved from nine scientific databases, including the MEDLINE via PubMed, Web of Science via the Web of Knowledge, Embase via Ovid, the Cochrane Central Register of Controlled Trials via the Cochrane Library, and Allied and Complementary Medicine Database via EBSCO, China National Knowledge Infrastructure, Wanfang Database, VIP Database, Chinese Biomedical Literature Database; three clinical registry platforms, including the WHO International Clinical Trials Registry Platform, NIH Clinical trials.gov and Chinese Clinical Trial Registry, as well as from other sources. Studies published since inception of these databases to 1 August 2021 will be retrieved. Search terms will include breathlessness, cancer, acupuncture and RCT. Two investigators will independently select and extract data from RCTs and assess the risk of bias. The primary outcome, which is alleviation of breathlessness, will be assessed. Meta-analysis will be performed using RevMan V.5.4 and STATA V.15.0. The TSA 0.9.5.10 β software will be used to conduct trial sequential analysis. Finally, the quality of evidence from RCTs will be assessed using the Grading of Recommendations Assessment, Development and Evaluation System tool.Ethics and disseminationResults will be disseminated through peer-reviewed journals or conference reports. Since this study involves acquisition of secondary data, ethical approval requirements will be waived.PROSPERO registration numberCRD42021240085.

show abstract

Acupuncture techniques for COPD: a systematic review

Cited by 12 publications

References 23 publications

Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis

Efficacy of acupuncture therapy for stable chronic obstructive pulmonary disease: A systematic review and meta-analysis

Acupuncture Point Stimulation Treatments Combined With Conventional Treatment in Chronic Obstructive Pulmonary Disease: A Systematic Review and Network Meta-Analysis

Acupuncture for breathlessness in advanced cancer: a protocol for systematic review and meta-analysis with trial sequential analysis

Contact Info

Product

Resources

About